Munich-based Wellster raises $60M to launch European femtech platform

Women’s health will be the focus of the new investment.

Since Wellster health platforms were launched in May 2019, they have registered more than 1.5 million patients who used them for mental and intimate health, hair and skin problems or medical self-testing – primarily for a male audience. Dr Manuel Nothelfer, Co-founder of Wellster Healthtech Group, declared: “The funding comes at a key point in our development. The Managing Partners at Mangrove Capital Partners stated: “What makes Wellster particularly attractive is the combination of an appealing offering that is directed to patients and a strong team that aims to shake up the huge European market.